The store will not work correctly when cookies are disabled.
1-(5-chloro-8-quinolyl)-N-[[(7S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl]methyl]methanamine
ID: ALA5093295
PubChem CID: 166633062
Max Phase: Preclinical
Molecular Formula: C18H19ClN4
Molecular Weight: 326.83
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccc(CNC[C@H]2CCn3ccnc3C2)c2ncccc12
Standard InChI: InChI=1S/C18H19ClN4/c19-16-4-3-14(18-15(16)2-1-6-22-18)12-20-11-13-5-8-23-9-7-21-17(23)10-13/h1-4,6-7,9,13,20H,5,8,10-12H2/t13-/m0/s1
Standard InChI Key: FHGRIXIUNQVDDZ-ZDUSSCGKSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
-2.8049 0.5850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0903 0.9973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3784 0.5855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3784 -0.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0885 -0.6514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8049 -0.2433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0842 -1.4733 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7959 -1.8900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5096 -1.4856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5194 -0.6617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5191 0.9974 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.6642 -0.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0499 -0.2396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7641 -0.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4783 -0.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4783 0.5849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1924 0.9973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9066 0.5849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9066 -0.2397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1924 -0.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5194 1.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3639 1.8038 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1841 1.8900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
5 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
6 10 1 0
1 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
15 14 1 6
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
20 19 1 0
15 20 1 0
18 21 1 0
17 22 2 0
22 23 1 0
23 21 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 326.83 | Molecular Weight (Monoisotopic): 326.1298 | AlogP: 3.44 | #Rotatable Bonds: 4 |
Polar Surface Area: 42.74 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.79 | CX LogP: 2.61 | CX LogD: 0.20 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.80 | Np Likeness Score: -1.08 |
References
1. Levit Kaplan A, Strachan RT, Braz JM, Craik V, Slocum S, Mangano T, Amabo V, O'Donnell H, Lak P, Basbaum AI, Roth BL, Shoichet BK.. (2022) Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor., 65 (5.0): [PMID:35195401] [10.1021/acs.jmedchem.1c02031] |